Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PF-004390
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical (eye Drops)
01
Overview
PF-004390 is an investigational drug formulated as eye drops. It has been studied in clinical trials designed to evaluate the efficacy of over-the-counter (OTC) eye drops for treating red eyes in healthy adults. The exact mechanism of action and therapeutic target of PF-004390 have not been publicly detailed. The drug appears to be developed for ocular use, likely targeting symptoms such as eye redness or irritation. The clinical trial context indicates it is a topical ophthalmic formulation intended to demonstrate therapeutic equivalence with other OTC eye drop products.
- Other names
- F# PF-004390 Eye Drops
Beyond the preview
Go deeper on PF-004390.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PF-004390.